7 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 19294542 | METHODS OF TREATMENT OF JAK INHIBITION RESPONSIVE CONDITIONS WITH DEUTERATED JAK INHIBITORS | HUTTER, GILLIAN A | 1625 | Non-Final OA | Aug 08, 2025 |
| 19273752 | ORAL FORMULATIONS OF DEURUXOLITINIB | WESTERBERG, NISSA M | 1618 | Final Rejection | Jul 18, 2025 |
| 19030287 | ADJUSTABLE ILLUMINATORS AND METHODS FOR PHOTODYNAMIC THERAPY AND DIAGNOSIS | NGANGA, BONIFACE N | 3797 | Non-Final OA | Jan 17, 2025 |
| 18013380 | METHODS AND INTERMEDIATES FOR PREPARING JAK INHIBITORS | O DELL, DAVID K | 1621 | Non-Final OA | Dec 28, 2022 |
| 18078571 | DEUTERATED DERIVATIVES OF RUXOLITINIB | MOORE, SUSANNA | 1624 | Non-Final OA | Dec 09, 2022 |
| 17981237 | PHOTODYNAMIC THERAPY ILLUMINATOR DEVICES AND METHODS | MULLINS, JESSICA LYNN | 3792 | Non-Final OA | Nov 04, 2022 |
| 17614323 | DEUTERATED ANALOGS OF D-SERINE AND USES THEREOF | ISMAIL, REHANA | 1625 | Non-Final OA | Nov 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial